Enzymatica AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 8.76 million compared to SEK 9.62 million a year ago. Net loss was SEK 11.51 million compared to SEK 15.36 million a year ago. Basic loss per share from continuing operations was SEK 0.07 compared to SEK 0.1 a year ago.
For the six months, sales was SEK 21.8 million compared to SEK 13.79 million a year ago. Net loss was SEK 26.43 million compared to SEK 33.41 million a year ago. Basic loss per share from continuing operations was SEK 0.16 compared to SEK 0.22 a year ago.